Trials / Unknown
UnknownNCT04596748
Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris
Prospective Randomized Double-Blind Placebo-Controlled Study of Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Integrative Skin Science and Research · Industry
- Sex
- All
- Age
- 13 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine how probiotics affect sebum production and gut health in those with acne vulgaris.
Detailed description
Probiotics have been shown in previous pilot studies to be helpful in acne and this study aims to examine how the gut microbiome and skin biophysical properties are shifted in those with acne vulgaris. In particular, this study will assess the influence of oral spore based probiotics on the skin sebum production and will assess how probiotics influence the gut microbiome and the blood levels of short chain fatty acids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic | Bacillus Subtilis, Bacillus Clausii, Bacillus Coagulans, Bacillus Indicus HU36, MCC 102 |
| DIETARY_SUPPLEMENT | Placebo | Placebo caps |
Timeline
- Start date
- 2020-05-11
- Primary completion
- 2021-03-01
- Completion
- 2021-03-01
- First posted
- 2020-10-22
- Last updated
- 2020-11-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04596748. Inclusion in this directory is not an endorsement.